Interesting literature
- In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials
- Importance and role of independent data monitoring committees (IDMCs) in oncology clinical trials
- ‘It’s misinformation at worst.’ Weak health studies can do more harm than good, scientists say
- European non-commercial sponsors showed substantial variation in results reporting to the EU trial registry
- Violation of research integrity principles occurs more often than we think
- Methodological quality of covid19 clinical research
- EU regulators’ perspectives to Decentralized Clinical Trials
- Tolerating bad health research: the continuing scandal
- Medicine’s Lessons for AI Regulation
- Rethinking the role of Research Ethics Committees in the light of Regulation (EU) No 536/2014 on clinical trials and the COVID-19 pandemic
- Parental perspectives on a trial using waived informed consent at birth
- Reframing consent for clinical research: a function-based approach
- Fourth controlled human infection model (CHIM) meeting, CHIM regulatory issues, May 24, 2023
